Ohio Public Employees Retirement System (OPERS)’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-16,800
Closed -$172K 2012
2024
Q1
$172K Buy
+16,800
New +$125K ﹤0.01% 1368
2023
Q2
Sell
-41,766
Closed -$272K 2015
2023
Q1
$272K Hold
41,766
﹤0.01% 1356
2022
Q4
$356K Sell
41,766
-6,187
-13% -$40.1K ﹤0.01% 1330
2022
Q3
$253K Buy
+47,953
New +$236K ﹤0.01% 1429
2022
Q2
Sell
-95,897
Closed -$337K 2035
2022
Q1
$337K Buy
95,897
+52,033
+119% +$227K ﹤0.01% 1401
2021
Q4
$292K Hold
43,864
﹤0.01% 1417
2021
Q3
$438K Buy
43,864
+31,382
+251% +$774K ﹤0.01% 1356
2021
Q2
$386K Hold
12,482
﹤0.01% 1383
2021
Q1
$545K Buy
12,482
+12,232
+4,893% +$579K ﹤0.01% 1310
2020
Q4
$12K Buy
+250
New +$8.35K ﹤0.01% 1931

Other funds holding SPRY

Ohio Public Employees Retirement System (OPERS)'s SPRY Position: Q2 2024 in Review

Ohio Public Employees Retirement System (OPERS) sold out of ARS Pharmaceuticals (SPRY) in Q2 2024, closing a stake of 16,800 shares — an estimated $172K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in SPRY in Q4 2020 and held it in 10 quarters. The position peaked at $545K in Q1 2021. 115 funds tracked by Wall St. Rank hold SPRY as of Q2 2024.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining ARS Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 16,800 ARS Pharmaceuticals shares in Q2 2024, an estimated $172K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in ARS Pharmaceuticals in Q4 2020 and held it in 10 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s ARS Pharmaceuticals position peaked at $545K in Q1 2021.
  • 115 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q2 2024.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2024, filed 14 Aug 2024.